+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
From
From
From
From
Acute Respiratory Distress Syndrome Treatment Market 2025-2029 - Product Thumbnail Image

Acute Respiratory Distress Syndrome Treatment Market 2025-2029

  • Report
  • January 2025
  • 193 Pages
  • Global
From
Montelukast Sodium Market 2024-2028 - Product Thumbnail Image

Montelukast Sodium Market 2024-2028

  • Report
  • October 2024
  • 140 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Drugs Market 2024-2028 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease Drugs Market 2024-2028

  • Report
  • August 2024
  • 168 Pages
  • Global
From
Bronchiectasis Drugs Market 2024-2028 - Product Thumbnail Image

Bronchiectasis Drugs Market 2024-2028

  • Report
  • July 2024
  • 174 Pages
  • Global
From
Pulmonary Edema Therapeutics Market 2024-2028 - Product Thumbnail Image

Pulmonary Edema Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
Sleep Apnea - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pneumococcal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Interstitial Lung Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Interstitial Lung Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025 - Product Thumbnail Image

Cough In Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight,2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more